o all importers and local manufacturers of pharmaceutical products,

You are hereby informed that NMRA would not register or renew existing of Topical applications containing an anti-bacterial, an antifungal and an anti-inflammatory agent in combination with effect from 17-02-2020.

Chief Executive officer NMRA

(Date: 10 July 2020)